ArriVent BioPharma, Inc. Common Stock vs Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi: Fair Value & Quality
Both stocks run through our valuation models. Here is how ArriVent BioPharma, Inc. Common Stock (AVBP) and Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi (FZLGY) compare, as of Sep 23, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | ArriVent BioPharma, Inc. Common StockPrice $30.32 | Fuzul Gayrimenkul Yatirim Ortakligi Anonim SirketiPrice TRY 7.57 |
|---|---|---|
| Multiples | n/a | ▼-79%below the priceTRY 1.62 |
| Asset-Based | ▼-86%below the price$4.17 | ▲+369%above the priceTRY 35.48 |
| Minimum | ▼-86%below the price$4.17 | ▼-79%below the priceTRY 1.62 |
| Maximum | ▼-86%below the price$4.17 | ▲+369%above the priceTRY 35.48 |
| Median | ▼-86%below the price$4.17 | ▲+145%above the priceTRY 18.55 |
| Geometric mean | ▼-86%below the price$4.17 | ●0%close to the priceTRY 7.58 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
ArriVent BioPharma, Inc. Common Stock: 1 of 1 models see the stock below the current price.
Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi: 3 of 4 models see the stock below the current price.
Scenario ranges
From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
ArriVent BioPharma, Inc. Common Stock · Health Care
Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi · Real Estate
Bottom line
As of Sep 23, 2026, Fair Value Calculator sees Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi as the less overvalued of the two: ArriVent BioPharma, Inc. Common Stock trades at $30.32 versus a fair value of $5.30 (-83%), while Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi trades at TRY 7.57 versus TRY 1.62 (-79%).
Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi has the higher quality score (35/100).
Open Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi live analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to ArriVent BioPharma, Inc. Common Stock
Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor ManufacturingRelated to Fuzul Gayrimenkul Yatirim Ortakligi Anonim Sirketi
Alphabet Inc Class C vs Meta PlatformsMicrosoft vs Taiwan Semiconductor ManufacturingBroadcom vs MicrosoftMicrosoft vs Micron TechnologySee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.